Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dellegra in Japanese Cedar Pollinosis
NCT02175485Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jun 2014
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Dellegra in allergic rhinitis (AR), sponsored by Sanofi. Started Jun 2014; status: completed.
02
Drugs
Dellegra
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT02175485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02175485.